<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01220804</url>
  </required_header>
  <id_info>
    <org_study_id>PTDC/SAU-BEB/103151/2008</org_study_id>
    <nct_id>NCT01220804</nct_id>
  </id_info>
  <brief_title>Evaluation of Blood-retinal Barrier Functional Alterations by Optical Coherence Tomography</brief_title>
  <acronym>CNTM025A OCT</acronym>
  <official_title>Evaluation of Blood-retinal Barrier Functional Alterations by Optical Coherence Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association for Innovation and Biomedical Research on Light and Image</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação para a Ciência e a Tecnologia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Financeiro para o Desenvolvimento Regional</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Association for Innovation and Biomedical Research on Light and Image</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify alterations of the blood-retinal barrier (BRB) in
      diabetic retinas using a novel non-invasive approach based on the Fourier domain
      high-definition optical coherence tomograph (OCT).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Type 2 diabetic patients with nonproliferative diabetic retinopathy (NPDR) (study population)
      and healthy volunteers (control population).

      Inclusion Criteria:

      Age over 18 years; type-2 diabetes; NPDR levels 10, 20 and 35/47 (ETDRS severity scale); and
      an area of retinal leakage of at least 25% of the RLA map (macular area).

      Exclusion Criteria:

      Presence of media opacity; vitreous syneresis or posterior vitreous detachment, and; previous
      photocoagulation treatments or any type of intraocular surgery or intravitreal medications;
      and other retinal pathologies.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Optical reflectivity as measured by optical coherence tomography</measure>
    <time_frame>14 months</time_frame>
    <description>To analyse OCT reflectivity distribution between areas with and without fluorescein leakage in type 2 diabetic eyes. In previous studies our group found differences, when comparing the histograms of the optical reflectivity distribution, suggesting that the optical reflectivity, as measured by OCT, may change under BRB alterations</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Diabetic Retinopathy</condition>
  <arm_group>
    <arm_group_label>NPDR</arm_group_label>
    <description>Type 2 diabetic patients with nonproliferative diabetic retinopathy (NPDR)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Population</arm_group_label>
    <description>Healthy volunteers</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Type 2 diabetic patients with nonproliferative diabetic retinopathy (NPDR) (study
        population) and healthy volunteers (control population).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18 years; type-2 diabetes; NPDR levels 10, 20 and 35/47 (ETDRS severity
             scale), and area of retinal leakage of at least 25% of the RLA map (macular area).

        Exclusion Criteria:

          -  Presence of media opacity; vitreous syneresis or posterior vitreous detachment, and;
             previous photocoagulation treatments or any type of intraocular surgery or
             intravitreal medications.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>AIBILI</name>
      <address>
        <city>Coimbra</city>
        <zip>3000-548</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <link>
    <url>http://www.aibili.pt</url>
  </link>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2010</study_first_submitted>
  <study_first_submitted_qc>October 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2010</study_first_posted>
  <last_update_submitted>April 22, 2016</last_update_submitted>
  <last_update_submitted_qc>April 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

